The American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, presented cutting-edge updates in hematology. Discover the top picks of this years meeting with Keith Stewart, MD, ChB, of the Mayo Clinic, Scottsdale, AZ. Dr Stewart highlights Phase III trials, antibody-drug conjugates and CAR T-cells, emphasizing key data showing the promise of particular therapies. He also discusses where he forsees CAR T-cell therapy moving in the next year.
ASH 2017 top picks: Phase III trials, antibody-drug conjugates and CAR T-cells
